Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Sales (2020 - 2025)

Historic Return on Sales for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to 4.37%.

  • Celularity's Return on Sales fell 26400.0% to 4.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.49%, marking a year-over-year decrease of 27600.0%. This contributed to the annual value of 1.07% for FY2024, which is 75500.0% up from last year.
  • Celularity's Return on Sales amounted to 4.37% in Q3 2025, which was down 26400.0% from 4.28% recorded in Q2 2025.
  • In the past 5 years, Celularity's Return on Sales registered a high of 12.67% during Q2 2022, and its lowest value of 30.64% during Q1 2021.
  • For the 5-year period, Celularity's Return on Sales averaged around 6.73%, with its median value being 1.73% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 328500bps in 2022, then tumbled by -289900bps in 2023.
  • Celularity's Return on Sales (Quarter) stood at 0.83% in 2021, then surged by 811bps to 5.92% in 2022, then tumbled by -87bps to 0.79% in 2023, then tumbled by -2551bps to 19.32% in 2024, then soared by 77bps to 4.37% in 2025.
  • Its Return on Sales was 4.37% in Q3 2025, compared to 4.28% in Q2 2025 and 1.73% in Q1 2025.